Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysis

BackgroundAntibodies against neuronal surface antigens (NSA-Abs), particularly against the NMDA receptor (NMDAR-Ab), have been reported in acute stroke patients (ASP). However, their role in stroke is far from being understood.MethodsWe conducted a systematic review and meta-analysis to investigate:...

Full description

Saved in:
Bibliographic Details
Main Authors: Matteo Paolucci, Andrea Zini, Luana Morelli, Rocco Liguori, Maria Pia Giannoccaro
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1491880/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841533213607985152
author Matteo Paolucci
Andrea Zini
Luana Morelli
Luana Morelli
Rocco Liguori
Rocco Liguori
Maria Pia Giannoccaro
Maria Pia Giannoccaro
author_facet Matteo Paolucci
Andrea Zini
Luana Morelli
Luana Morelli
Rocco Liguori
Rocco Liguori
Maria Pia Giannoccaro
Maria Pia Giannoccaro
author_sort Matteo Paolucci
collection DOAJ
description BackgroundAntibodies against neuronal surface antigens (NSA-Abs), particularly against the NMDA receptor (NMDAR-Ab), have been reported in acute stroke patients (ASP). However, their role in stroke is far from being understood.MethodsWe conducted a systematic review and meta-analysis to investigate: 1) the frequency of NSA-Abs in patients with acute stroke compared to controls; 2) the de novo appearance of NSA-Abs after stroke; and 3) their effects on the clinical outcome.ResultsWe included nine studies in the qualitative analysis and seven in the quantitative analysis. Analyses were restricted to NMDAR-Abs due to the lack of data about other NSA-Abs. Considering only studies that adopted a cell-based assay, IgA-IgM NMDAR-Abs isotypes (but not the IgG) were found more frequently in patients with acute stroke (OR 2.69, 95% CI 2.00–3.62, I2 = 4%). There was no de novo NMDAR-Abs formation after stroke. There was no statistical difference in mean discharge/day–7 NIHSS (SMD 0.21, 95% CI -1.10–1.52, I2 = 84%) and 3–12-month mRS (SMD 0.38, 95% CI -0.56-1.32, I2 = 78%) between patients with stroke with and without NMDAR-Abs seropositivity.ConclusionsSerum IgA/IgM NMDAR-Abs are more frequent in patients with stroke than controls. Due to several methodological issues, these findings should be interpreted cautiously. Additional, methodologically robust studies are needed to clarify the prevalence and significance of NMDAR-Abs in patients with stroke.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022241278#:~:text=https%3A//www.crd.york.ac.uk/prospero/display_record.php%3FID%3DCRD42022241278, identifier CRD42022241278.
format Article
id doaj-art-14aa6cdbca4c46b0b20f5bd00489f0fa
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-14aa6cdbca4c46b0b20f5bd00489f0fa2025-01-17T05:10:36ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011610.3389/fimmu.2025.14918801491880Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysisMatteo Paolucci0Andrea Zini1Luana Morelli2Luana Morelli3Rocco Liguori4Rocco Liguori5Maria Pia Giannoccaro6Maria Pia Giannoccaro7IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna, ItalyIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna, ItalyIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Ospedale Bellaria, Bologna, ItalyDipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, ItalyIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Ospedale Bellaria, Bologna, ItalyDipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, ItalyIRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Ospedale Bellaria, Bologna, ItalyDipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, ItalyBackgroundAntibodies against neuronal surface antigens (NSA-Abs), particularly against the NMDA receptor (NMDAR-Ab), have been reported in acute stroke patients (ASP). However, their role in stroke is far from being understood.MethodsWe conducted a systematic review and meta-analysis to investigate: 1) the frequency of NSA-Abs in patients with acute stroke compared to controls; 2) the de novo appearance of NSA-Abs after stroke; and 3) their effects on the clinical outcome.ResultsWe included nine studies in the qualitative analysis and seven in the quantitative analysis. Analyses were restricted to NMDAR-Abs due to the lack of data about other NSA-Abs. Considering only studies that adopted a cell-based assay, IgA-IgM NMDAR-Abs isotypes (but not the IgG) were found more frequently in patients with acute stroke (OR 2.69, 95% CI 2.00–3.62, I2 = 4%). There was no de novo NMDAR-Abs formation after stroke. There was no statistical difference in mean discharge/day–7 NIHSS (SMD 0.21, 95% CI -1.10–1.52, I2 = 84%) and 3–12-month mRS (SMD 0.38, 95% CI -0.56-1.32, I2 = 78%) between patients with stroke with and without NMDAR-Abs seropositivity.ConclusionsSerum IgA/IgM NMDAR-Abs are more frequent in patients with stroke than controls. Due to several methodological issues, these findings should be interpreted cautiously. Additional, methodologically robust studies are needed to clarify the prevalence and significance of NMDAR-Abs in patients with stroke.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022241278#:~:text=https%3A//www.crd.york.ac.uk/prospero/display_record.php%3FID%3DCRD42022241278, identifier CRD42022241278.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1491880/fullneuronal surface antigensNMDA receptor antibodiesstroke outcomeischemic strokeantibody isotypes
spellingShingle Matteo Paolucci
Andrea Zini
Luana Morelli
Luana Morelli
Rocco Liguori
Rocco Liguori
Maria Pia Giannoccaro
Maria Pia Giannoccaro
Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysis
Frontiers in Immunology
neuronal surface antigens
NMDA receptor antibodies
stroke outcome
ischemic stroke
antibody isotypes
title Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysis
title_full Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysis
title_fullStr Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysis
title_full_unstemmed Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysis
title_short Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysis
title_sort antibodies against neuronal surface antigens in acute stroke a systematic review and meta analysis
topic neuronal surface antigens
NMDA receptor antibodies
stroke outcome
ischemic stroke
antibody isotypes
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1491880/full
work_keys_str_mv AT matteopaolucci antibodiesagainstneuronalsurfaceantigensinacutestrokeasystematicreviewandmetaanalysis
AT andreazini antibodiesagainstneuronalsurfaceantigensinacutestrokeasystematicreviewandmetaanalysis
AT luanamorelli antibodiesagainstneuronalsurfaceantigensinacutestrokeasystematicreviewandmetaanalysis
AT luanamorelli antibodiesagainstneuronalsurfaceantigensinacutestrokeasystematicreviewandmetaanalysis
AT roccoliguori antibodiesagainstneuronalsurfaceantigensinacutestrokeasystematicreviewandmetaanalysis
AT roccoliguori antibodiesagainstneuronalsurfaceantigensinacutestrokeasystematicreviewandmetaanalysis
AT mariapiagiannoccaro antibodiesagainstneuronalsurfaceantigensinacutestrokeasystematicreviewandmetaanalysis
AT mariapiagiannoccaro antibodiesagainstneuronalsurfaceantigensinacutestrokeasystematicreviewandmetaanalysis